多西环素联用阿莫西林克拉维酸钾治疗耐药幽门螺杆菌感染临床研究

Clinical Study of Doxycycline Combined with Amoxicillin Clavulanate Potassium in the Treatment of Drug-Resistant Helicobacter Pylori Infection

目的:分析研究多西环素联用阿莫西林克拉维酸钾应用于治疗耐药幽门螺杆菌(HP)感染的临床效果。方法:将我院收治的60例HP感染者,分为治疗组与对照组,每组各30例。治疗组采用多西环素联用阿莫西林克拉维酸钾。对照组采用传统的治疗方法。对比两种治疗方法的效果。结果:多西环素联合阿莫西林克拉维酸钾治疗耐药HP感染要明显高于传统的治疗方法,有利于治疗耐药HP感染。结论:多西环素联合用阿莫西林克拉维酸钾应用于耐药HP感染患者的治疗,体现出临床效果显著、缩短治疗时间、保证患者的生活质量等优势,对于改善临床症状具有推动作用,具有推广应用价值。

Objective: To analyze the clinical effect of doxycycline combined with amoxicillin clavulanate potassium in the treatment of drug-resistant helicobacter pylori(HP) infection.Methods: 60 cases of HP infection in our hospital were divided into treatment group and control group,30 cases in each group.The treatment group was treated with doxycycline combined with amoxicillin clavulanate potassium.The control group received conventional treatment.Compare the effects of the two treatments.Results: Doxycycline combined with amoxicillin clavulanate was significantly higher in the treatment of drug-resistant HP infection than the traditional treatment methods,which was beneficial to the treatment of drug-resistant HP infection.Conclusion: The application of doxycycline combined with amoxicillin clavulanate in the treatment of patients with drug-resistant HP infection shows significant clinical effects,shortening the treatment time,ensuring the quality of life of patients and other advantages,promoting the improvement of clinical symptoms,with the value of popularization and application.